Where does BioLegend, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), BioLegend, Inc. ranks #28,253 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does BioLegend, Inc. hold?

BioLegend, Inc. holds 9 US utility patents granted between 2020 and 2025, spanning 13 technology areas.

What is BioLegend, Inc.'s Innovation Score?

BioLegend, Inc. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does BioLegend, Inc. focus on?

BioLegend, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 8 patents, ranking #1,791 of 7,863 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is BioLegend, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for BioLegend, Inc..

What does claim depth mean for BioLegend, Inc.'s patents?

BioLegend, Inc.'s patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the BioLegend, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

BioLegend, Inc.

USPTO PatentsView assignee record - 9 granted patents across 13 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biolegend ranks #28,253 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 13 technology areas.

#28,253
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 14.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R28253 · US Corporation #28,253 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #28,253/49,997
PHOTO-FINISH Bigtec Private
CPC-FOCUS G01N · 13 areas
INNOV-PAR 40.2/100
CLAIMS-RICH 14.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Bigtec Private Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biolegend’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (20%) Velocity 11.1 pts (28%) Breadth 12.7 pts (32%) Claim depth 8.4 pts (21%)

Qualcomm Incorporated · highest

85
BioLegend · this assignee

40
3D Lighting… · lowest

7

What this shows Biolegend's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biolegend?

Each dot is one of Biolegend’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biolegend’s own 14.0 claims/patent is at or below the 16.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Biolegend vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biolegend's grants concentrate

BioLegend, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 88.9% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2021. By volume, Biolegend sits between Bigtec Private Limited and Bioserenity.

Biolegend's three-year grant acceleration

BioLegend, Inc. shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bigtec Private

9
Bill & Melinda Ga…

9
Binatone Internat…

9
Bioage Labs

9
Biopharmx

9
Biomet Microfixat…

9
Bioness Neuromodu…

9
Bioserenity

9
Biolegend ◀

9

What this shows BioLegend holds 9 patents at rank #28,280, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near BioLegend

By rank, the assignees closest to #28,280 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in BioLegend's primary technology class.

Biolegend's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

BioLegend, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	22.2%
2021	1	11.1%
2023	3	33.3%
2024	2	22.2%
2025partial year	1	11.1%

Which technologies does BioLegend, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 4

C07K - Peptides 2

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 2

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 2

C07D - Heterocyclic Compounds 2

C07C - Acyclic OR Carbocyclic Compounds 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

BioLegend, Inc.'s patent record in context - here's where to go next.

BioLegend, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 88.9% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #28,253 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare BioLegend, Inc. against Bigtec Private Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.